Basic fibroblast growth factor expression in recurrent versus non-recurrent nasal polyposis

European Archives of Oto-Rhino-Laryngology

Volumn 261, Issue 6, 2004, Pages 321-325

  Cayé Thomasen, Per ^a   Larsen, Knud ^b   Tingsgaard, Peter ^a   Tos, Mirko ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b ENT Clinic   (Denmark)

Author keywords

Asthma; Histopathology; Immunohistochemistry; Polyp; Polypectomy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ADOLESCENT; ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE POLYP; POLYPECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NOSE NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 3242885547     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Baird A, Klagsbrun M (1991) The fibroblast growth factor family. Cancer Cells 3:239-243
2. Bikfalvi A, Klein S, Pintucci G, Rifkin DB (1997) Biological roles of fibroblast growth factor-2. Endocr Rev 18:26-45
3. Coste A, Wang QP, Roudot-Thoraval F, chapelin C, Bedbeder P, Poron F, Peynegre R, Escudier E (1996) Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor. Laryngoscope 106:578-583
4. Coste A, Wang QP, Lefaucheur JO, Lesprit E, Poron F, Peynegre R, Escudier E (1996) Transforming growth facto-beta expression in inflammatory mucosa from upper airways. Am J Respir Crit Care Med 153:636
5. Coste A, Brugel L, Maitre B, Boussat S, Papon JF, Wingerstmann L, Peynegre R, Escudier E (2000) Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 15:367-372
6. Elovic A, Wong D, Weller P, Matossian K, Galli SJ (1994) Expression of transgenic growth factor beta-1 messenger mRNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 93:864-869
7. Fernig DG, Gallagher JT (1994) Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 5:353-377
8. Goldfarb M (1990) The fibroblast growth factor family. Cell Growth Differ 1:439-445
9. Ishibashi T, Tanaka T, Nibu K, Ishimoto S, Kaga K (1998) Keratinocyte growth factor and its receptor messenger RNA expression in nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 107:885-890
10. Ito A, Hirota S, Mizuno H, Kawasaki Y, Takemura T, Nishiura T, Kanakura Y, Katayama Y, Nomura S, Kitamura Y (1995) Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathol Int 45:715-20
11. Larsen K (1996) The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc 17:243-249
12. Larsen K, Tos M (1997) A long-term follow-up study of nasal polyp patients after simple polypectomies. Eur Arch Otorhinolaryngol 254:85-88
13. Norlander T, Westermark A, van Setten G, Valtonen H, Ishizaki H, Pyykko I (2001) Basic fibroblast growth factor in nasal polyps. Immunohistochemical and quantitative findings. Rhinology 39:88-92
14. Ohno I, Lea RG, Finotto S, Marshall J, Denburg J, Dolovich J, Gauldie J, Jordana M (1991) Granulocyte macrophage colony-stimulating factor gene expression by eosinophils in nasal polyposis. Am J Respir Cell Mol Biol 5:505-510
15. Ohno I, Lea RG, Flanders KC, Clark DA, Banwatt D, Dolovich J, Denburg J, Harley CB, Gauldie J, Jordana M (1992) Eosinophils in chronically inflamed human upper airway tissue express transforming growth factor-beta 1 gene. J Clin Invest 89:1662-1668
16. Partanen J, Vainikka S, Korhonen J, Armstrong E, Alitalo K (1992) Diverse receptors for fibroblast growth factors. Prog Growth Factor Res 4:69-83
17. Petruson B, Hansson H-A, Petruson K (1988) Insulin-like growth factor I is a possible pathogenic mechanism in nasal polyps. Acta Otolaryngol (Stockh) 106:156-160
18. Powers MR, Qu Z, Lagesse PC, Liebler JM, Wall MA, Rosenbaum JT (1998) Expression of basic fibroblast growth factor in nasal polyps. Ann Otol Rhinol Laryngol 107:891-897
19. Ristimäki A, Narko K, Enholm B, Joukov V, Alitalo K (1998) Pro-inflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273:8413-8418
20. Silvestri M, Sabatini F, Scarso L, Cordone A, Dasic G, Rossi GA (2002) Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. Int Arch Allergy Immunol 128:51-58
21. Slavin J (1995) Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 19:431-444
22. Szebenyi G, Fallon JF (1999) Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 185:45-106
23. Tingsgaard PK, Bock T, Larsen PL, Tos M (1999) Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps. Acta Otolaryngol 119:362-368
24. Tos M (1995) Nasal polyps. Curr Opin Otolaryngol Head Neck Surg 3:31-35
25. Vento SL, Wolff CH, Salven PJ, Hytonen ML, Ertama LO, Malmberg CH (2000) Vascular permeability factor/vascular endothelial growth factor in nasal polyps. Acta Otolaryngol [Suppl] 543:170-174
26. Wang QP, Escudier E, Roudot-Thoraval F, Samad IAA, Peynegre R, Coste A (1997) Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 107:926-931
27. Wittekindt C, Hess A, Bloch W, Sultanie S, Michel O (2002) Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 259:294-298